Sintx Technologies Appoints CEO Eric Olson to Board

Sintx Technologies ( (SINT) ) has shared an update.

SINTX Technologies, Inc. has appointed Eric K. Olson, its current CEO and President, to its Board of Directors. Olson, who has a rich history in leading biotech firms like Foresite Innovations and Predictive Biotech, brings extensive experience in healthcare innovation and development. His leadership roles in major companies such as Smith & Nephew and Johnson & Johnson further bolster his credentials, making him a strategic asset to SINTX as it navigates the evolving financial landscape. Notably, Olson does not receive additional compensation for his board position, aligning his interests with the company’s growth.

See more insights into SINT stock on TipRanks’ Stock Analysis page.